Earnings Labs
BridgeBio Pharma, Inc. logo

BridgeBio Pharma, Inc. (BBIO) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$69.59

Mkt Cap $14.77B

EPS — Estimate vs Actual

Revenue — Estimate vs Actual

Quarterly History

Q1 2026

Feb 24, 2026

$146.84M$154.18M+5.00%-$0.71-$1.00-40.17%
Q4 2025

Oct 29, 2025

$148.15M$120.70M-18.53%-$0.88-$0.95-7.95%
Q3 2025

Aug 5, 2025

$108.13M$110.56M+2.26%-$0.83-$0.95-14.46%
Q2 2025

Apr 29, 2025

$68.41M$116.63M+70.48%-$1.00-$0.88+12.00%
Q1 2025

Feb 20, 2025

$4.04M$5.88M+45.62%-$1.09-$1.31-20.18%
Q4 2024

Nov 12, 2024

$67.32M$2.73M-95.94%-$1.03-$0.86+16.50%
Q3 2024

Aug 1, 2024

$3.57M$2.17M-39.27%-$1.09-$1.02+6.42%
Q2 2024

May 2, 2024

$14.03M$211.12M+1404.78%-$0.40-$0.05+87.50%
Q1 2024

Feb 22, 2024

$6.23M$1.75M-71.99%-$0.95-$0.96-1.05%
Q4 2023

Nov 2, 2023

$4.26M$4.09M-3.97%-$0.86-$1.08-25.58%
Q3 2023

Aug 3, 2023

$2.99M$1.64M-45.12%-$0.86-$0.98-13.95%
Q2 2023

May 4, 2023

$3.37M$1.83M-45.82%-$0.84-$0.92-9.52%
Q1 2023

Feb 23, 2023

$4.52M$1.87M-58.67%-$0.86-$0.87-1.16%
Q4 2022

Nov 3, 2022

$4.09M$338.00K-91.73%-$1.02-$0.93+8.82%
Q3 2022

Aug 4, 2022

$27.19M$73.75M+171.23%-$0.92-$0.81+11.96%
Q2 2022

May 5, 2022

$4.70M$1.69M-63.92%-$1.13-$1.19-5.31%
Q1 2022

Feb 24, 2022

$21.56M$12.89M-40.24%-$0.83-$1.01-21.69%
Q4 2021

Nov 4, 2021

$15.10M$2.34M-84.48%-$0.91-$1.06-16.48%
Q3 2021

Aug 5, 2021

$34.84M$54.02M+55.06%-$0.93-$0.66+29.03%
Q2 2021

May 6, 2021

$14.75M$462.00K-96.87%-$0.87-$1.18-35.63%
Q1 2021

Feb 25, 2021

$16.93M$122.00K-99.28%-$0.86-$1.01-17.44%
Q4 2020

Nov 5, 2020

$7.63M$8.13M+6.52%-$0.97-$0.98-1.03%
Q3 2020

Aug 11, 2020

-$0.79-$1.03-30.38%
Q2 2020

May 13, 2020

-$0.69-$0.78-13.04%
Q1 2020

Mar 2, 2020

$15.60M$13.82M-11.43%-$0.70-$0.62+11.43%
Q4 2019

Nov 7, 2019

$28.84M$26.74M-7.27%-$0.55-$0.51+7.27%
Q3 2019

Aug 14, 2019

-$0.52-$3.46-565.38%
Q2 2019

Jun 28, 2019

-$0.42
Q1 2019

Mar 31, 2019

-$0.51
Q3 2018

Sep 30, 2018

-$0.34
Q2 2018

Jun 30, 2018

-$0.29
Q1 2018

Mar 31, 2018

-$0.37